← Latest news 
Hims & Hers shares plunge after earnings shock despite a brighter full year forecast
Business
Published on 11 May 2026
A revenue boost could not offset a surprise loss
Hims & Hers Health shares fell sharply after reporting a surprise first-quarter loss and revenue that missed expectations. The company, however, raised its full-year revenue outlook and signaled stronger second-quarter sales. The stock reaction underscores how investors are weighing results against ongoing regulatory scrutiny tied to weight-loss drugs and pricing momentum.
- Hims & Hers reported a surprise first-quarter loss
- Revenue came in below analyst expectations
- Full-year guidance was raised and second-quarter outlook improved
- Regulatory pressure around weight-loss drugs remains a key risk
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times